
Talk Liver To Me - Hepatocellular Carcinoma: Who to screen, when, and how?
Notes de l’épisode
Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk profiles and variation across guidelines have added complexity to clinical decision-making. In this podcast, we revisit the fundamentals of HCC screening, focusing on practical, evidence-based approaches to patient selection, timing, and surveillance strategies.
Host: Mattias Mandorfer (Medical University of Vienna)
Guests: Peter Jepsen (Aarhus University), Amit Singal (UT Southwestern Medical Center)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-20
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-20).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.